-
Mylan markets generic Solodyn ER
PITTSBURGH Mylan has launched a generic treatment for acne, the company said Thursday.
Mylan announced the launch of minocycline hydrochloride extended-release tablets in the 45 mg, 90 mg and 135-mg strengths. The drug is a generic version of Solodyn ER, made by Medicis Pharmaceuticals Corp.
Minocycline ER had sales of around $496 million during the 12-month period ended in March, according to IMS Health.
-
GPhA: Generic drug utilization can curb wasteful Medicaid spending
WASHINGTON A reported excess of a quarter billion dollars is a good case for increasing use of generic drugs under the Medicaid program, according to the main lobby for the generic drug industry.
Responding to a report by conservative think tank the American Enterprise Institute that identified $271 million in wasteful Medicaid spending, the Generic Pharmaceutical Association said it was a “compelling case” for increasing generic drug utilization.